Cited by 286Cardiovascular Function and Risk FactorsHeart Failure Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction

Open access

Dries, Daniel L, Sweitzer, Nancy K, Drazner, Mark H, Stevenson, Lynne W, Gersh, Bernard J·2001·Journal of the American College of Cardiology

DOI 10.1016/s0735-1097(01)01408-5

Open this paper in CoChat — free account

Abstract

Objectives We sought to determine the relative impact of diabetes mellitus on prognosis in ischemic compared with nonischemic cardiomyopathy.Background Ischemic myocardium is characterized by increased reliance on aerobic and anaerobic glycolysis. Because glucose utilization by cardiomyocytes is an insulin-mediated process, we hypothesized that diabetes would have a more adverse impact on mortality and progression of heart failure in ischemic compared with nonischemic cardiomyopathy.Methods We performed a retrospective analysis of the Studies Of Left Ventricular Dysfunction (SOLVD) Prevention and Treatment trials.Results In adjusted analyses, diabetes mellitus was strongly associated with an increased risk for all-cause mortality in patients with ischemic cardiomyopathy, (relative risk [RR] 1.37, 95% confidence interval [CI] 1.21 to 1.55; p < 0.0001), but not in those with nonischemic cardiomyopathy (RR 0.98, 95% CI 0.76 to 1.32; p = 0.98). The increased mortality in patients with ischemic cardiomyopathy compared with nonischemic cardiomyopathy was limited to those with ischemic cardiomyopathy and diabetes mellitus (RR 1.37, 95% CI 1.21 to 1.56; p < 0.0001). When patients with ischemic cardiomyopathy and diabetes mellitus were excluded, there was no significant difference in mortality risk between the ischemic and nonischemic cardiomyopathy groups after adjusted analysis (RR 0.99, 95% CI 0.86 to 1.15; p = 0.99). Previous surgical revascularization identified patients within the cohort with ischemic cardiomyopathy and diabetes mellitus, with improved prognosis.Conclusions The differential impact of diabetes on mortality and heart failure progression according to the etiology of heart failure suggests that diabetes and ischemic heart disease interact to accelerate the progression of myocardial dysfunction. Evaluation of the potential for revascularization may be particularly important in patients with ischemic cardiomyopathy and diabetes mellitus.

Integrity signals

Registry

Crossref · 10.1016/s0735-1097(01)01408-5

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Diabetes and Cardiovascular Disease: A Statement for Healthcare Professionals From the American Heart Association
Grundy, S. M., Benjamin, I. J., Burke, G. L., Chait, A., Eckel, R. H., Howard, B. V., Mitch, W., Smith, S. C., & Sowers, J. R. (1999) · Circulation · doi:10.1161/01.cir.100.10.1134 · Cited by 2,698
Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry
Shindler, D. M., Kostis, J. B., Yusuf, S., Quinones, M. A., Pitt, B., Stewart, D., Pinkett, T., Ghali, J. K., Wilson, A. C., & The SOLVD Investigators (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89163-1 · Cited by 516
Acute Coronary Findings at Autopsy in Heart Failure Patients With Sudden Death
Uretsky, B. F., Thygesen, K. A., Armstrong, P. W., Cleland, J. G. F., Horowitz, J. D., Massie, B. M., Packer, M., Poole-Wilson, P. A., & Rydén, L. (2000) · Circulation · doi:10.1161/01.cir.102.6.611 · Cited by 336
Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb Study
McGuire, D. K. (2000) · European Heart Journal · doi:10.1053/euhj.2000.2317 · Cited by 178
Actions of insulin on the mammalian heart: metabolism, pathology and biochemical mechanisms
Brownsey, R. W. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00051-5 · Cited by 132
Effects of Dobutamine Stimulation on Myocardial Blood Flow, Glucose Metabolism, and Wall Motion in Normal and Dysfunctional Myocardium
Sun, K., Czernin, J. G., Krivokapich, J., Lau, Y., Bøttcher, M., Maurer, G., Phelps, M. E., & Schelbert, H. R. (1996) · Circulation · doi:10.1161/01.cir.94.12.3146 · Cited by 116
Diabetes and Cardiovascular Disease
Johnstone, M. T., & Veves, A. (2001) · Humana Press eBooks · doi:10.1385/1592590918 · Cited by 106
Etiology and response to drug treatment in heart failure
Folláth, F., Cleland, J. G. F., Klein, W., & Murphy, R. L. W. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00400-8 · Cited by 106
Mechanical and metabolic functions in pig hearts after 4 days of chronic coronary stenosis
Liedtke, A. J., Renstrøm, B., Nellis, S. H., Hall, J. L., & Stanley, W. C. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00223-q · Cited by 60
Studies of left ventricular dysfunction (SOLVD) registry: Rationale, design, methods and description of baseline characteristics
Bangdiwala, S. I., Weiner, D. H., Bourassa, M. G., Friesinge, G. C., Ghali, J. K., Yusuf, S., & The SOLVD Investigators (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90617-8 · Cited by 50

Show all 19 references

Sorted by citations

Multi-Ethnic Study of Atherosclerosis: Objectives and Design
Bild, D. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf113 · Cited by 3,942
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)
Swedberg, K. B., Cleland, J. G. F., Dargie, H., Drexler, H., Folláth, F., Michel Komajda, N., Tavazzi, L., Smiseth, O. A., Gavazzi, A., Haverich, A., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi204 · Cited by 2,259
Cardiac Energy Metabolism in Heart Failure
Lopaschuk, G. D., Karwi, Q. G., Tian, R., Wende, A. R., & Abel, E. D. (2021) · Circulation Research · doi:10.1161/circresaha.121.318241 · Cited by 1,458
Predictors of mortality and morbidity in patients with chronic heart failure
Pocock, S., Wang, D., Pfeffer, M. A., Yusuf, S., McMurray, J. J. V., Swedberg, K. B., Östergren, J., Michelson, E. L., Pieper, K. S., & Granger, C. B. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi555 · Cited by 972
Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology
Seferović, P. M., Petrie, M. C., Filippatos, G. S., Anker, S. D., Rosano, G., Bauersachs, J., Paulus, W. J., Komajda, M., Cosentino, F., de Boer, R. A., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1170 · Cited by 708
Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme
MacDonald, M. R., Petrie, M. C., Varyani, F., Ostergren, J., Michelson, E. L., Young, J. B., Solomon, S. D., Granger, C. B., Swedberg, K., Yusuf, S., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn153 · Cited by 694
Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association
Bozkurt, B., Aguilar, D. A., Deswal, A. M., Dunbar, S. B., Francis, G. S., Horwich, T. B., Jessup, M. L., Kosiborod, M., Pritchett, A. M., Ramasubbu, K., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000450 · Cited by 556
Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status
Shekelle, P. G., Rich, M. W., Morton, S. C., Atkinson, C. S. W., Tu, W., Maglione, M., Rhodes, S., Barrett, M., Fonarow, G. C., Greenberg, B., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00262-6 · Cited by 492
Copper, Chromium, Manganese, Iron, Nickel, and Zinc Levels in Biological Samples of Diabetes Mellitus Patients
Kazi, T. G., Afridi, H. I., Kazi, N. G., Jamali, M. K., Arain, M. B., Jalbani, N. B., & Kandhro, G. A. (2008) · Biological Trace Element Research · doi:10.1007/s12011-007-8062-y · Cited by 482
Medical Management of Advanced Heart Failure
Nohria, A. (2002) · JAMA · doi:10.1001/jama.287.5.628 · Cited by 466
Insulin Signaling and Heart Failure
Riehle, C., & Abel, E. D. (2016) · Circulation Research · doi:10.1161/circresaha.116.306206 · Cited by 420
Navigating the Crossroads of Coronary Artery Disease and Heart Failure
Gheorghiade, M., Sopko, G. S., Luca, L. D., Velazquez, E. J., Parker, J. D., Binkley, P. F., Sadowski, Z., Golba, K. S., Prior, D., Rouleau, J. L., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.623199 · Cited by 408
Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment
Falcão‐Pires, I., & Leite-Moreira, A. F. (2011) · Heart Failure Reviews · doi:10.1007/s10741-011-9257-z · Cited by 369
Prevention Conference VI: Diabetes and Cardiovascular Disease
Howard, B. V., Rodríguez, B. L., Bennett, P. H., Harris, M. I., Hamman, R. F., Kuller, L. H., Pearson, T. A., & Wylie‐Rosett, J. (2002) · Circulation · doi:10.1161/01.cir.0000013953.41667.09 · Cited by 307
Diabetes in heart failure: prevalence and impact on outcome in the population
From, A. M., Leibson, C. L., Bursi, F., Redfield, M. M., Weston, S. A., Jacobsen, S. J., Rodeheffer, R. J., & Roger, V. L. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.05.024 · Cited by 295
Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure
Gustafsson, I., Brendorp, B., Seibæk, M., Burchardt, H., Hildebrandt, P., Køber, L., & Torp-Pedersen, C. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.11.024 · Cited by 258
The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron
Silverberg, D. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/18.1.141 · Cited by 257
The Epidemiology of Asymptomatic Left Ventricular Systolic Dysfunction: Implications for Screening
Wang, T. J., Levy, D., Benjamin, E. J., & Vasan, R. S. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-11-200306030-00012 · Cited by 229
Diabetes, left ventricular systolic dysfunction, and chronic heart failure
MacDonald, M. R., Petrie, M. C., Hawkins, N. M., Petrie, J. R., Fisher, M., McKelvie, R., Aguilar, D., Krum, H., & McMurray, J. J. V. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn156 · Cited by 227
Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure
Siirilä‐Waris, K., Lassus, J. P. E., Melin, J., PEUHKURINEN, K. J., Nieminen, M. S., Harjola, V., & for the FINN-AKVA study group (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl407 · Cited by 227
The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial
Domanski, M., Krause-Steinrauf, H., Deedwania, P., Follmann, D., Ghali, J. K., Gilbert, E., Haffner, S., Katz, R., Lindenfeld, J., Lowes, B. D., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00856-8 · Cited by 215
Influence of diabetes mellitus on heart failure risk and outcome
Bauters, C., Lamblin, N., Fadden, E. P. M., BELLE, E. V., Millaire, A., & de Groote, P. (2003) · Cardiovascular Diabetology · doi:10.1186/1475-2840-2-1 · Cited by 214
Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure
Smooke, S., Horwich, T. B., & Fonarow, G. C. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.07.005 · Cited by 196
Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome
Bugger, H., & Abel, E. D. (2008) · Clinical Science · doi:10.1042/cs20070166 · Cited by 197
Of mice and men: models and mechanisms of diabetic cardiomyopathy
Riehle, C., & Bauersachs, J. K. (2018) · Basic Research in Cardiology · doi:10.1007/s00395-018-0711-0 · Cited by 204
Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)
Greenberg, B. H., Abraham, W. T., Albert, N. M., Chiswell, K., Clare, R., Stough, W. G., Gheorghiade, M., O'Connor, C. M., Sun, J. L., Yancy, C. W., et al. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.05.001 · Cited by 196
Are β-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials
Haas, S. J., Vos, T., Gilbert, R. E., & Krum, H. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00403-4 · Cited by 194
Impact of diabetes mellitus on long-term survival in patients with congestive heart failure
de Groote, P. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.01.010 · Cited by 192
Gene expression analysis of ischemic and nonischemic cardiomyopathy: shared and distinct genes in the development of heart failure
Kittleson, M. M., Minhas, K. M., Irizarry, R. A., Ye, S. Q., Edness, G., Breton, E., Conte, J. V., Tomaselli, G. F., Garcia, J. G. N., & Hare, J. M. (2005) · Physiological Genomics · doi:10.1152/physiolgenomics.00255.2004 · Cited by 173
Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET)
Torp-Pedersen, C., Metra, M., Charlesworth, A., Spark, P., Lukas, M. A., Poole-Wilson, P. A., Swedberg, K., Cleland, J. G. F., Di Lenarda, A., Remme, W. J., et al. (2007) · Heart · doi:10.1136/hrt.2006.092379 · Cited by 171
Development of Congestive Heart Failure in Type 2 Diabetic Patients With Microalbuminuria or Proteinuria
Vaur, L., Gueret, P., Lievre, M., Chabaud, S., Passa, P., & For the DIABHYCAR Study Group (2003) · Diabetes Care · doi:10.2337/diacare.26.3.855 · Cited by 163
Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality
Kittleson, M. M., Hurwitz, S., Shah, M., Nohria, A., Lewis, E. F., Givertz, M. M., Fang, J. C.-T., Jarcho, J. A., Mudge, G. H., & Stevenson, L. W. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00417-0 · Cited by 160
Demographics and concomitant disorders in heart failure
Krum, H., & Gilbert, R. E. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13869-x · Cited by 161
LCZ696, An Angiotensin Receptor–Neprilysin Inhibitor, Improves Cardiac Function with the Attenuation of Fibrosis in Heart Failure with Reduced Ejection Fraction in Streptozotocin-Induced Diabetic Mice
Suematsu, Y., Miura, S., Goto, M., Matsuo, Y., Arimura, T., Kuwano, T., Imaizumi, S., Iwata, A., Yahiro, E., & Saku, K. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.474 · Cited by 156
An unexpected inverse relationship between HbA1c levels and mortality in patients with diabetes and advanced systolic heart failure
Eshaghian, S., Horwich, T. B., & Fonarow, G. C. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.10.008 · Cited by 145
Association between diabetes and 1-year adverse clinical outcomes in a multinational cohort of ambulatory patients with chronic heart failure: results from the ESC-HFA heart failure long-term registry
Dauriz, M., Targher, G., Laroche, C., Temporelli, P. L., Ferrari, R., Anker, S., Coats, A., Filippatos, G., Crespo-Leiro, M., Mebazaa, A., et al. (2017) · Diabetes Care · doi:10.2337/dc16-2016 · Cited by 139
A multivariate model for predicting mortality in patients with heart failure and systolic dysfunction
Brophy, J. M., Dagenais, G. R., McSherry, F., Williford, W., & Yusuf, S. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.09.035 · Cited by 136
Predictors of Mortality in 6975 Patients With Chronic Heart Failure in the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico-Heart Failure Trial
Barlera, S., Tavazzi, L., Franzosi, M. G., Marchioli, R., Raimondi, E., Masson, S., Urso, R., Lucci, D., Nicolosi, G. L., Maggioni, A. P., et al. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.967828 · Cited by 129
Identification of a Gene Expression Profile That Differentiates Between Ischemic and Nonischemic Cardiomyopathy
Kittleson, M. M., Ye, S. Q., Irizarry, R. A., Minhas, K. M., Edness, G., Conte, J. V., Parmigiani, G., Miller, L. W., Chen, Y., Hall, J. L., et al. (2004) · Circulation · doi:10.1161/01.cir.0000148178.19465.11 · Cited by 127
Type 2 Diabetes and Heart Failure: Challenges and Solutions
Thomas, M. C. (2016) · Current Cardiology Reviews · doi:10.2174/1573403x12666160606120254 · Cited by 117
Frequent Non-Cardiac Comorbidities in Patients with Chronic Heart Failure
Dahlström, U. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.01.008 · Cited by 114
Guías de Práctica Clínica sobre el diagnóstico y tratamiento de la insuficiencia cardíaca crónica. Versión resumida (actualización 2005)
de Diagnóstico, G. D. T., & de Cardiología, T. D. L. I. C. C. D. L. S. E. (2005) · Revista Española de Cardiología · doi:10.1157/13078554 · Cited by 113
Gut microbiota, endotoxemia, inflammation, and oxidative stress in patients with heart failure, left ventricular assist device, and transplant
Yuzefpolskaya, M., Bohn, B., Nasiri, M., Zuver, A., Onat, D., Royzman, E. A., Nwokocha, J., Mabasa, M., Pinsino, A., Brunjes, D., et al. (2020) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2020.02.004 · Cited by 102
Chronic obstructive pulmonary disease in heart failure. Prevalence, therapeutic and prognostic implications
Mascarenhas, J., Lourenço, P., Lopes, R., Azevedo, A., & Bettencourt, P. (2008) · American Heart Journal · doi:10.1016/j.ahj.2007.10.040 · Cited by 109
Efficacy of angiotensin-converting enzyme inhibition in reducing progression from asymptomatic left ventricular dysfunction to symptomatic heart failure in black and white patients
Dries, D. L., Strong, M. H., Cooper, R., & Drazner, M. H. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01943-5 · Cited by 109
Prognostic Implications of Type 2 Diabetes Mellitus in Ischemic and Nonischemic Heart Failure
Johansson, I., Dahlström, U., Edner, M., Näsman, P., Rydén, L., & Norhammar, A. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.06.061 · Cited by 100
Carbonic Anhydrase Activation Is Associated With Worsened Pathological Remodeling in Human Ischemic Diabetic Cardiomyopathy
Torella, D., Ellison, G. M., Torella, M., Vicinanza, C., Aquila, I., Iaconetti, C., Scalise, M., Marino, F., Henning, B. J., Lewis, F., et al. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000434 · Cited by 99
The Future of Heart Failure Diagnosis, Therapy, and Management
Udelson, J. E., & Stevenson, L. W. (2016) · Circulation · doi:10.1161/circulationaha.116.023518 · Cited by 99
Anaemia in diabetes: is there a rationale to TREAT?
Thomas, M. C., Cooper, M. E., Rossing, K., & Parving, H. ‐. (2006) · Diabetologia · doi:10.1007/s00125-006-0215-6 · Cited by 95
Heart Failure and Diabetes Mellitus: Epidemiology and Management of an Alarming Association
Solal, A. C., Beauvais, F., & Logeart, D. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.04.001 · Cited by 94
Metabolic and Molecular Imaging of the Diabetic Cardiomyopathy
Peterson, L. R., & Gropler, R. J. (2020) · Circulation Research · doi:10.1161/circresaha.120.315899 · Cited by 93
Diabetes Mellitus and Heart Failure: Epidemiology, Mechanisms, and Pharmacotherapy
Masoudi, F. A., & Inzucchi, S. E. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.11.013 · Cited by 89
Effects of MEK5/ERK5 Association on Small Ubiquitin-Related Modification of ERK5: Implications for Diabetic Ventricular Dysfunction After Myocardial Infarction
Shishido, T., Woo, C.-H., Ding, B., McClain, C., Molina, C. A. F., Chen, Y., Yang, J., & Abe, J. (2008) · Circulation Research · doi:10.1161/circresaha.107.168138 · Cited by 80
Cardiovascular Disease and Diabetes
Bloomgarden, Z. T. (2003) · Diabetes Care · doi:10.2337/diacare.26.1.230 · Cited by 80
Diabetes and Cardiovascular Disease: Changing the Focus from Glycemic Control to Improving Long-Term Survival
Wang, C. C. L., & Reusch, J. E. B. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.08.036 · Cited by 78
Pulmonary artery stents: Long‐term follow‐up
Law, M. A., Shamszad, P., Nugent, A. W., Justino, H., Breinholt, J. P., Mullins, C. E., & Ing, F. F. (2009) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.22356 · Cited by 78
Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trial
Komajda, M., Tavazzi, L., Francq, B. G., Böhm, M., Borer, J. S., Ford, I., & Swedberg, K. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.347 · Cited by 76
Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure
Metra, M., Zacà, V., Parati, G., Agostoni, P., Bonadies, M., Ciccone, M. M., Dei, A., Iacoviello, M., Lagioia, R., Lombardi, C., et al. (2010) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e32834058d1 · Cited by 73
Prognostic impact of diabetes mellitus in patients with heart failure and preserved ejection fraction: a prospective five-year study
Tribouilloy, C. M., Ruşinaru, D., Mahjoub, H., Tartiere, J.-H., Tartière-Kesri, L., Godard, S., & Peltier, M. (2008) · Heart · doi:10.1136/hrt.2007.128769 · Cited by 71
Prognostic impact of diabetes and prediabetes on survival outcomes in patients with chronic heart failure: a post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) Trial
Dauriz, M., Targher, G., Temporelli, P. L., Lucci, D., Gonzini, L., Nicolosi, G. L., Marchioli, R., Tognoni, G., Latini, R., Cosmi, F., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005156 · Cited by 70
Influence of diabetes on the survival of patients hospitalized with heart failure: a 12-year study
Varela-Roman, A., Shamagian, L. G., Caballero, E. B., Ramos, P. M., Veloso, P. R., & Gonzalez-Juanatey, J. R. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.01.017 · Cited by 69
Non-cardiovascular comorbidity, severity and prognosis in non-selected heart failure populations: A systematic review and meta-analysis
Rushton, C. A., Satchithananda, D. K., Jones, P. W., & Kadam, U. T. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.05.180 · Cited by 69
Nature and prognostic importance of abnormal glucose tolerance and diabetes in acute heart failure
Berry, C., Brett, M., Stevenson, K. S., McMurray, J. J. V., & Norrie, J. D. (2007) · Heart · doi:10.1136/hrt.2006.110999 · Cited by 69
Effects of diabetes mellitus and ischemic heart disease on the progression from asymptomatic left ventricular dysfunction to symptomatic heart failure: a retrospective analysis from the Studies of Left Ventricular Dysfunction (SOLVD) Prevention trial
Das, S. R., Drazner, M. H., Yancy, C. W., Stevenson, L. W., Gersh, B. J., & Dries, D. L. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.04.019 · Cited by 68
Co-morbidities in heart failure
van Deursen, V. M., Damman, K., van der Meer, P., Wijkstra, P. J., Luijckx, G. J., van Beek, A. P., van Veldhuisen, D. J., & Voors, A. A. (2012) · Heart Failure Reviews · doi:10.1007/s10741-012-9370-7 · Cited by 67
The effect of carvedilol on mortality risk in heart failure patients with diabetes: results of a meta-analysis
Bell, D. S. H., Ann Lukas, M., Holdbrook, F. K., & Fowler, M. B. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x80459 · Cited by 66
Animal models of insulin resistance and heart failure
Velez, M., Kohli, S., & Sabbah, H. N. (2013) · Heart Failure Reviews · doi:10.1007/s10741-013-9387-6 · Cited by 66
Prognostic Impact of NT-proBNP and Renal Function in Comparison to Contemporary Multi-Marker Risk Scores in Heart Failure Patients
Pfister, R., Diedrichs, H., Schiedermair, A., Rosenkranz, S., Hellmich, M., Erdmann, E., & Schneider, C. A. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.01.009 · Cited by 67
The Interplay Between Continuity of Care, Multimorbidity, and Adverse Events in Patients With Diabetes
Weir, D. L., McAlister, F. A., Majumdar, S. R., & Eurich, D. T. (2016) · Medical Care · doi:10.1097/mlr.0000000000000493 · Cited by 62
A comparative study of discriminating human heart failure etiology using gene expression profiles
Huang, X., Pan, W., Grindle, S. M., Han, X., Chen, Y., Park, S. J., Miller, L. W., & Hall, J. L. (2005) · BMC Bioinformatics · doi:10.1186/1471-2105-6-205 · Cited by 62
Third heart sound and elevated jugular venous pressure as markers of the subsequent development of heart failure in patients with asymptomatic left ventricular dysfunction
Drazner, M. H., Rame, J. E., & Dries, D. L. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00058-5 · Cited by 61
Acute heart failure in patients with diabetes mellitus: clinical characteristics and predictors of in-hospital mortality
Parissis, J. T., Rafouli-Stergiou, P., Mebazaa, A., Ikonomidis, I., Bistola, V., Nikolaou, M., Meas, T., Delgado, J., Vilas-Boas, F., Paraskevaidis, I., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.11.098 · Cited by 58
The effect of glycaemic control and glycaemic variability on mortality in patients hospitalized with congestive heart failure
Dungan, K. M., Binkley, P. F., Nagaraja, H. N., Schuster, D., & Osei, K. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1155 · Cited by 59
Type 2 diabetes mellitus: a cardiovascular perspective
Varughese, G. I., Tomson, J., & Lip, G. Y. H. (2005) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2005.00571.x · Cited by 57
The Diabetic Disadvantage: Historical Outcomes Measures in Diabetic Patients Undergoing Cardiac Surgery—The Pre-Intravenous Insulin Era
Brown, J. R., Edwards, F. H., O’Connor, G. T., Ross, C. S., & Furnary, A. P. (2006) · Seminars in Thoracic and Cardiovascular Surgery · doi:10.1053/j.semtcvs.2006.04.004 · Cited by 57
Telecardiology for patients with chronic heart failure: the ‘SHL’ experience in Israel
Roth, A., Kajiloti, I., Elkayam, I., Sander, J., Kehati, M., & Golovner, M. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.07.030 · Cited by 55
Type 2 diabetes and heart failure: characteristics and prognosis in preserved, mid-range and reduced ventricular function
Johansson, I., Dahlström, U., Edner, M., Näsman, P., Rydén, L., & Norhammar, A. (2018) · Diabetes and Vascular Disease Research · doi:10.1177/1479164118794619 · Cited by 51
Type 2 Diabetes Mellitus and Impact of Heart Failure on Prognosis Compared to Other Cardiovascular Diseases
Zareini, B., Blanche, P., D’Souza, M., Malik, M. E., Nørgaard, C. H., Selmer, C., Gislason, G., Kristensen, S. L., Køber, L., Torp-Pedersen, C. T., et al. (2020) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.119.006260 · Cited by 54
Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT)
Martin, D. T., McNitt, S., Nesto, R. W., Rutter, M. K., & Moss, A. J. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.110.959510 · Cited by 51
Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure
Ghali, J. K., Boehmer, J., Feldman, A. M., Saxon, L. A., Demarco, T., Carson, P., Yong, P., Galle, E. G., Leigh, J., Ecklund, F. L., et al. (2007) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.06.723 · Cited by 50
The High Prevalence of Anemia in Diabetes Is Linked to Functional Erythropoietin Deficiency
Thomas, M. C. (2006) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2006.05.003 · Cited by 49
A pilot test of an integrated self-care intervention for persons with heart failure and concomitant diabetes
Dunbar, S. B., Butts, B., Reilly, C. M., GARY, R. A., Higgins, M. K., Ferranti, E. P., Culler, S. D., & Butler, J. (2013) · Nursing Outlook · doi:10.1016/j.outlook.2013.09.003 · Cited by 48
Long-Term Outcome in Diabetic Heart Failure Patients Treated with Cardiac Resynchronization Therapy
Fantoni, C., Regoli, F. D., Ghanem, A., Raffa, S., Klersy, C., Sorgente, A., Faletra, F. F., Baravelli, M., Inglese, L., Salerno‐Uriarte, J. A., et al. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.01.006 · Cited by 49
Early diagnosis of left ventricular diastolic dysfunction in diabetic patients: a possible role for natriuretic peptides
Romano, S., Mauro, M. D., Fratini, S., Guarracini, L., Guarracini, F., Poccia, G., & Penco, M. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-89 · Cited by 48
Impact of Diabetes and Sex in Heart Failure with Reduced Ejection Fraction Patients from the ASIAN-HF Registry
Chandramouli, C., Teng, T. K., Tay, W. T., Yap, J. J. L., MacDonald, M. R., Tromp, J., Yan, L., Siswanto, B. B., Reyes, E. B., Ngarmukos, T., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1358 · Cited by 48
Cardiovascular Disease in Diabetes
Bloomgarden, Z. T. (2010) · Diabetes Care · doi:10.2337/dc10-zb04 · Cited by 49
Insuficiência cardíaca descompensada
Mangini, S., Pires, P. V., Marcondes‐Braga, F. G., & Bacal, F. (2013) · Einstein (São Paulo) · doi:10.1590/s1679-45082013000300022 · Cited by 54
Impact of Nutrition on Cardiovascular Function
Bianchi, V. E. (2018) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2018.08.003 · Cited by 47
Impaired Glucose Metabolism in Patients with Heart Failure
Tenenbaum, A., & Fisman, E. Z. (2004) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200404050-00001 · Cited by 46
Assessment of Cost and Health Resource Utilization for Elderly Patients With Heart Failure and Diabetes Mellitus
Bogner, H. R., Miller, S. D., de Vries, H. F., Chhatre, S., & Jayadevappa, R. (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.01.007 · Cited by 45
Effects of the Early ACE Inhibition in Diabetic Nonthrombolyzed Patients With Anterior Acute Myocardial Infarction
Borghi, C., Bacchelli, S., Esposti, D. D., Ambrosioni, E., & on behalf of the SMILE Study Investigators (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1862 · Cited by 44
Effect of cardiac resynchronization on morbidity and mortality of diabetic patients with severe heart failure
Hoppe, U. C., Freemantle, N., Cleland, J. G. F., Marijianowski, M., & Erdmann, E. (2007) · Diabetes Care · doi:10.2337/dc06-2035 · Cited by 43
Thiazolidinediones in Type 2 Diabetes: A Cardiology Perspective
Khanderia, U., Pop‐Busui, R., & Eagle, K. A. (2008) · Annals of Pharmacotherapy · doi:10.1345/aph.1k666 · Cited by 43
Morbidity and mortality in diabetic patients following cardiac transplantation
Lang, C. C., Beniaminovitz, A., Edwards, N. M., & MANCINI, D. M. (2003) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(02)00567-3 · Cited by 43
Pathological Effects of Exosomes in Mediating Diabetic Cardiomyopathy
Salem, E., & Fan, G. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-4397-0_8 · Cited by 42
Influence of diabetes mellitus and hyperglycemia on prognosis in patients ≥70 years old with heart failure and effects of nebivolol (data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with heart failure [SENIORS])
de Boer, R. A., Doehner, W., van der Horst, I. C. C., Anker, S. D., Babalis, D., Roughton, M., Coats, A. J., Flather, M. D., & van Veldhuisen, D. J. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.02.018 · Cited by 39
Association of Antidiabetic Medications Targeting the Glucagon-Like Peptide 1 Pathway and Heart Failure Events in Patients With Diabetes
Velez, M., Peterson, E. L., Wells, K. E., Swadia, T. V., Sabbah, H. N., Williams, L. K., & Lanfear, D. E. (2014) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2014.10.012 · Cited by 40
Heart Failure and Diabetes Mellitus: Defining the Problem and Exploring the Interrelationship
Wilkinson, M. J., Zadourian, A., & Taub, P. R. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.10.024 · Cited by 40
Effect of diabetes mellitus on myocardial 18F-FDG SPECT using acipimox for the assessment of myocardial viability.
Schinkel, A. F. L., Bax, J. J., Valkema, R., Elhendy, A., van Domburg, R. T., Vourvouri, E. C., Bountioukos, M., Krenning, E. P., Roelandt, J. R. T. C., & Poldermans, D. (2003) · PubMed · Cited by 39
Impact of race on morbidity and mortality in patients with congestive heart failure: A study of the multiracial population in Singapore
Lee, R., Chan, S., Chan, Y., Wong, J. S., Lau, D., & Ng, K. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.12.107 · Cited by 37

Authors: Dries, D. L., Sweitzer, N. K., Drazner, M. H., Stevenson, L. W., & Gersh, B. J.
Affiliations: The University of Texas Southwestern Medical Center (US)
Brigham and Women's Hospital (US)
Mayo Clinic (US)
Corresponding author: Dries, Daniel L
ORCID: Sweitzer, Nancy K
Drazner, Mark H
Stevenson, Lynne W
Gersh, Bernard J
Venue: Journal of the American College of Cardiology
Publisher: Elsevier BV
Published: 2001-08
Volume: 38
Issue: 2
Pages: 421-428
ISSN: 0735-1097 (ISSN-L)
DOI: 10.1016/s0735-1097(01)01408-5
OpenAlex: W2110103927
Cited by: 286
References: 19
Citations by year: 2026: 1 · 2025: 1 · 2024: 5 · 2023: 1 · 2022: 9 · 2021: 3 · 2020: 17 · 2019: 9 · 2018: 17 · 2017: 9 · 2016: 12 · 2015: 9 · 2014: 11 · 2013: 9 · 2012: 12
FWCI: 10.96
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 4367 d)
Locations: Journal of the American College of Cardiology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: diabetes mellitus, heart failure, left ventricular systolic dysfunction, ischemic cardiomyopathy, non-ischemic cardiomyopathy, all-cause mortality, heart failure progression, revascularization, myocardial glucose utilization, insulin, SOLVD trial
MeSH terms: Coronary Artery Bypass, Female, Heart Failure, Humans, Male, Middle Aged, Prognosis, Retrospective Studies, Risk Factors, Systole, Cohort Studies, Survival Rate, Myocardial Ischemia, Ventricular Dysfunction, Left, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks